Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

View source ↗

Summary

A recruiting clinical trial in China aims to study protein molecular characteristics and prognosis of cervical neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fujian Maternity and Child Health Hospital | Conditions: Neuroendocrine Neoplasm, China | Status: RECRUITING